-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Relay Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2019 to 2024.
- Relay Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$81.4 M, a 13.6% increase year-over-year.
- Relay Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$329 M, a 1.99% decline year-over-year.
- Relay Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$342 M, a 17.7% decline from 2022.
- Relay Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$291 M, a 20.2% increase from 2021.
- Relay Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$364 M, a 594% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)